Nabla Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$70M
- Investors
-
15
Nabla Bio General Information
Description
Developer of wet-lab technologies designed for the rational design of developable, selective, and functional drugs. The company offers integrated AI-driven modeling, high-throughput multiplex screening, and wet-lab validation, enabling pharmaceutical companies to create drugs against previously undruggable targets with enhanced precision and efficacy.
Contact Information
Website
www.nabla.bioCorporate Office
- Riverside Technology Center
- 840 Memorial Drive
- Cambridge, MA 02139
- United States
Corporate Office
- Riverside Technology Center
- 840 Memorial Drive
- Cambridge, MA 02139
- United States
Nabla Bio Timeline
Nabla Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B) | 15-May-2026 | $70M | Completed | Generating Revenue | ||
| 6. Early Stage VC (Series A) | 14-May-2024 | Completed | Generating Revenue | |||
| 5. Seed Round | 20-Feb-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Sep-2021 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Nabla Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 307,138 | $0.000100 | 8% | $0.49 | $0.49 | 1x | $0.49 | 2.92% |
| Seed | 1,657,301 | $0.000100 | 8% | $6.07 | $6.07 | 1x | $6.07 | 15.75% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nabla Bio Comparisons
Industry
Financing
Details
Nabla Bio Competitors (36)
One of Nabla Bio’s 36 competitors is BigHat Biosciences, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BigHat Biosciences | Venture Capital-Backed | San Mateo, CA | ||||
| InterAx | Venture Capital-Backed | Schlieren, Switzerland | ||||
| AbCellera Biologics | Formerly VC-backed | Vancouver, Canada | ||||
| Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom | ||||
| BPS Bioscience | Corporation | San Diego, CA |
Nabla Bio Patents
Nabla Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12040050-B1 | Systems and methods for rational protein engineering with deep representation learning | Active | 06-Mar-2019 |
Nabla Bio Signals
Nabla Bio Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BluePointe Ventures | Venture Capital | Minority | ||
| Braidwell | Hedge Fund | Minority | ||
| GRIDS Capital | Venture Capital | Minority | ||
| Radical Ventures | Venture Capital | Minority | ||
| Boom Capital Ventures | Venture Capital | Minority |
Nabla Bio FAQs
-
When was Nabla Bio founded?
Nabla Bio was founded in 2020.
-
Where is Nabla Bio headquartered?
Nabla Bio is headquartered in Cambridge, MA.
-
What is the size of Nabla Bio?
Nabla Bio has 22 total employees.
-
What industry is Nabla Bio in?
Nabla Bio’s primary industry is Drug Discovery.
-
Is Nabla Bio a private or public company?
Nabla Bio is a Private company.
-
What is the current valuation of Nabla Bio?
The current valuation of Nabla Bio is .
-
What is Nabla Bio’s current revenue?
The current revenue for Nabla Bio is .
-
How much funding has Nabla Bio raised over time?
Nabla Bio has raised $107M.
-
Who are Nabla Bio’s investors?
BluePointe Ventures, Braidwell, GRIDS Capital, Radical Ventures, and Boom Capital Ventures are 5 of 15 investors who have invested in Nabla Bio.
-
Who are Nabla Bio’s competitors?
BigHat Biosciences, InterAx, AbCellera Biologics, Sygnature Discovery, and BPS Bioscience are some of the 36 competitors of Nabla Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process